Access Questions Surround New Twice-Yearly HIV Prevention Injection
A new twice-yearly injection offers revolutionary HIV prevention, prompting global debates over pharmaceutical pricing, public funding, and equitable acces
A new twice-yearly injection offers revolutionary HIV prevention, prompting global debates over pharmaceutical pricing, public funding, and equitable acces